Verratti Mark (CIK 1517026) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-15). Recent activity: Sell MYGN (1,069 shares), Sell MYGN (2,055 shares), Buy MYGN (247,423 shares), Sell MYGN (9,164 shares), Sell MYGN (5,418 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-15 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Sell | 1,069 | $5,249 |
| 2026-03-23 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Sell | 2,055 | $9,412 |
| 2026-03-16 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Buy | 247,423 | $0 |
| 2026-03-16 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Sell | 9,164 | $42,704 |
| 2026-03-16 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Sell | 5,418 | $25,248 |
| 2026-03-16 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Sell | 5,611 | $26,147 |
| 2026-03-16 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Sell | 9,096 | $42,387 |
| 2026-02-03 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Buy | 32,810 | $0 |
| 2025-09-22 | MYRIAD GENETICS INC (MYGN) | Chief Operating Officer | Sell | 1,085 | $8,430 |
| 2025-04-15 | MYRIAD GENETICS INC (MYGN) | Chief Commercial Officer | Sell | 1,085 | $8,767 |
来源：SEC Form 4 申报文件 · 截至 2026-04-15